Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cell Line Authentication and Characterization Tests Market

4. Market Overview
4.1. Introduction
4.1.1. Test Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cell Line Authentication and Characterization Tests Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
5.1. Standards for Cell Authentication and Characteristics
5.2. List of Cell Line Providers
5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.4. Key Product/Brand Analysis
5.5. COVID-19 Pandemics Impact on Industry (value chain and short / mid /long term impact)

6. Global Cell Line Authentication and Characterization Tests Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Test Type, 2017–2031
6.3.1. Karyotype
6.3.2. Short Tandem Repeat (STR) Analysis
6.3.3. Single Nucleotide Polymorphism (SNP) Analysis
6.3.4. Others
6.4. Market Attractiveness Analysis, by Test Type

7. Global Cell Line Authentication and Characterization Tests Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Microbial Contamination
7.3.2. Cell Line Identity
7.3.3. Genetic Stability
7.3.4. Virus Testing
7.3.5. Others
7.4. Market Attractiveness Analysis, by Application

8. Global Cell Line Authentication and Characterization Tests Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Pharmaceutical & Biotechnology Companies
8.3.2. Academic & Research Institutes
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user

9. Global Cell Line Authentication and Characterization Tests Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Sub-region/Region

10. North America Cell Line Authentication and Characterization Tests Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Test Type, 2017–2031
10.2.1. Karyotype
10.2.2. Short Tandem Repeat (STR) Analysis
10.2.3. Single Nucleotide Polymorphism (SNP) Analysis
10.2.4. Others
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Microbial Contamination
10.3.2. Cell Line Identity
10.3.3. Genetic Stability
10.3.4. Virus Testing
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Pharmaceutical & Biotechnology Companies
10.4.2. Academic & Research Institutes
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Test Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country

11. Europe Cell Line Authentication and Characterization Tests Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Test Type, 2017–2031
11.2.1. Karyotype
11.2.2. Short Tandem Repeat (STR) Analysis
11.2.3. Single Nucleotide Polymorphism (SNP) Analysis
11.2.4. Others
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Microbial Contamination
11.3.2. Cell Line Identity
11.3.3. Genetic Stability
11.3.4. Virus Testing
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Pharmaceutical & Biotechnology Companies
11.4.2. Academic & Research Institutes
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Test Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region

12. Asia Cell Line Authentication and Characterization Tests Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Test Type, 2017–2031
12.2.1. Karyotype
12.2.2. Short Tandem Repeat (STR) Analysis
12.2.3. Single Nucleotide Polymorphism (SNP) Analysis
12.2.4. Others
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Microbial Contamination
12.3.2. Cell Line Identity
12.3.3. Genetic Stability
12.3.4. Virus Testing
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Pharmaceutical & Biotechnology Companies
12.4.2. Academic & Research Institutes
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia
12.6. Market Attractiveness Analysis
12.6.1. By Test Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region

13. Latin America Cell Line Authentication and Characterization Tests Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Test Type, 2017–2031
13.2.1. Karyotype
13.2.2. Short Tandem Repeat (STR) Analysis
13.2.3. Single Nucleotide Polymorphism (SNP) Analysis
13.2.4. Others
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Microbial Contamination
13.3.2. Cell Line Identity
13.3.3. Genetic Stability
13.3.4. Virus Testing
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Pharmaceutical & Biotechnology Companies
13.4.2. Academic & Research Institutes
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Test Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Cell Line Authentication and Characterization Tests Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Test Type, 2017–2031
14.2.1. Karyotype
14.2.2. Short Tandem Repeat (STR) Analysis
14.2.3. Single Nucleotide Polymorphism (SNP) Analysis
14.2.4. Others
14.3. Market Value Forecast By Application, 2017–2031
14.3.1. Microbial Contamination
14.3.2. Cell Line Identity
14.3.3. Genetic Stability
14.3.4. Virus Testing
14.3.5. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Pharmaceutical & Biotechnology Companies
14.4.2. Academic & Research Institutes
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Test Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis By Company (2020)
15.3. Company Profiles
15.3.1. Bio-Synthesis, Inc.
15.3.1.1. Company Description
15.3.1.2. Business Overview
15.3.1.3. SWOT Analysis
15.3.2. Cell Line Genetics, Inc.
15.3.2.1. Company Description
15.3.2.2. Business Overview
15.3.2.3. SWOT Analysis
15.3.3. Charles River Laboratories
15.3.3.1. Company Description
15.3.3.2. Business Overview
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.4. DNA Forensics Lab India
15.3.4.1. Company Description
15.3.4.2. Business Overview
15.3.4.3. SWOT Analysis
15.3.5. Eurofins Genomics (Eurofins Scientific)
15.3.5.1. Company Description
15.3.5.2. Business Overview
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.6. GenomeScan
15.3.6.1. Company Description
15.3.6.2. Business Overview
15.3.6.3. SWOT Analysis
15.3.7. IDEXX Laboratories, Inc.
15.3.7.1. Company Description
15.3.7.2. Business Overview
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.8. Laboratory Corporation of America Holdings
15.3.8.1. Company Description
15.3.8.2. Business Overview
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.9. Microsynth AG
15.3.9.1. Company Description
15.3.9.2. Business Overview
15.3.9.3. SWOT Analysis
15.3.10. NorthGene Limited (Biofortuna Limited)
15.3.10.1. Company Description
15.3.10.2. Business Overview
15.3.10.3. SWOT Analysis
15.3.11. Perfectus Biomed Limited
15.3.11.1. Company Description
15.3.11.2. Business Overview
15.3.11.3. SWOT Analysis
15.3.12. Promega Corporation
15.3.12.1. Company Description
15.3.12.2. Business Overview
15.3.12.3. Financial Overview
15.3.12.4. Strategic Overview
15.3.12.5. SWOT Analysis
15.3.13. SGS SA
15.3.13.1. Company Description
15.3.13.2. Business Overview
15.3.13.3. Financial Overview
15.3.13.4. SWOT Analysis
15.3.14. Sigma-Aldrich Co. LLC. (Merck KGaA)
15.3.14.1. Company Description
15.3.14.2. Business Overview
15.3.14.3. Financial Overview
15.3.14.4. Strategic Overview
15.3.14.5. SWOT Analysis
15.3.15. Thermo Fisher Scientific, Inc.
15.3.15.1. Company Description
15.3.15.2. Business Overview
15.3.15.3. Financial Overview
15.3.15.4. Strategic Overview
15.3.15.5. SWOT Analysis



List of Figures

List of Figures

Figure 01: Global Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 02: Global Cell Line Authentication and Characterization Tests Market Value Share (%), by Region, 2020

Figure 03: Global Cell Line Authentication and Characterization Tests Market Value Share (%), by Test Type, 2020

Figure 04: Global Cell Line Authentication and Characterization Tests Market Value Share (%), by Application, 2020

Figure 05: Global Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 06: Global Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 07: Global Cell Line Authentication and Characterization Tests Market Value (US$ Mn), Karyotype, 2017–2031

Figure 08: Global Cell Line Authentication and Characterization Tests Market Value (US$ Mn), Short Tandem Repeat (STR) Analysis, 2017–2031

Figure 09: Global Cell Line Authentication and Characterization Tests Market Value (US$ Mn), Single Nucleotide Polymorphism (SNP) Analysis, 2017–2031

Figure 10: Global Cell Line Authentication and Characterization Tests Market Value (US$ Mn), Others, 2017–2031

Figure 11: Global Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Application, 2021 and 2031

Figure 12: Global Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Application, 2021–2031

Figure 13: Global Cell Line Authentication and Characterization Tests Market Revenue (US$ Mn), by Microbial Contamination, 2017–2031

Figure 14: Global Cell Line Authentication and Characterization Tests Market Revenue (US$ Mn), by Cell Line Identity, 2017–2031

Figure 15: Global Cell Line Authentication and Characterization Tests Market Revenue (US$ Mn), by Genetic Stability, 2017–2031

Figure 16: Global Cell Line Authentication and Characterization Tests Market Revenue (US$ Mn), by Virus Testing, 2017–2031

Figure 17: Global Cell Line Authentication and Characterization Tests Market Revenue (US$ Mn), by Others, 2017–2031

Figure 18: Global Cell Line Authentication and Characterization Tests Market Value Share Analysis, by End-user, 2020 and 2031

Figure 19: Global Cell Line Authentication and Characterization Tests Market attractiveness index Analysis, by End-user, 2021–2031

Figure 20: Global Cell Line Authentication and Characterization Tests Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017–2031

Figure 21: Global Cell Line Authentication and Characterization Tests Market Revenue (US$ Mn), by Academic & Research Institutes, 2017–2031

Figure 22: Global Cell Line Authentication and Characterization Tests Market Revenue (US$ Mn), by Others, 2017–2031

Figure 23: Global Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Region, 2021 and 2031

Figure 24: Global Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Region, 2021–2031

Figure 25: North America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 26: North America Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Country, 2020 and 2031

Figure 27: North America Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Country, 2021–2031

Figure 28: North America Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 29: North America Cell Line Authentication and Characterization Tests Market Attractiveness Index Analysis, by Test Type, 2021–2031

Figure 30: North America Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Application, 2020 and 2031

Figure 31: North America Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Application, 2021–2031

Figure 32: North America Cell Line Authentication and Characterization Tests Market Value Share Analysis, by End-user, 2020 and 2031

Figure 33: North America Cell Line Authentication and Characterization Tests Market attractiveness index Analysis, by End-user, 2021–2031

Figure 34: Europe Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 35: Europe Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 36: Europe Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 37: Europe Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 38: Europe Cell Line Authentication and Characterization Tests Market Attractiveness Index Analysis, by Test Type, 2021–2031

Figure 39: Europe Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Application, 2020 and 2031

Figure 40: Europe Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Application, 2021–2031

Figure 41: Europe Cell Line Authentication and Characterization Tests Market Value Share Analysis, by End-user, 2020 and 2031

Figure 42: Europe Cell Line Authentication and Characterization Tests Market attractiveness index Analysis, by End-user, 2021–2031

Figure 43: Asia Pacific Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 44: Asia Pacific Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 45: Asia Pacific Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 46: Asia Pacific Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 47: Asia Pacific Cell Line Authentication and Characterization Tests Market Attractiveness Index Analysis, by Test Type, 2021–2031

Figure 48: Asia Pacific Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Application, 2020 and 2031

Figure 49: Asia Pacific Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Application, 2021–2031

Figure 50: Asia Pacific Cell Line Authentication and Characterization Tests Market Value Share Analysis, by End-user, 2020 and 2031

Figure 51: Asia Pacific Cell Line Authentication and Characterization Tests Market attractiveness index Analysis, by End-user, 2021–2031

Figure 52: Latin America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 53: Latin America Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 54: Latin America Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 55: Latin America Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 56: Latin America Cell Line Authentication and Characterization Tests Market Attractiveness Index Analysis, by Test Type, 2021–2031

Figure 57: Latin America Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Application, 2020 and 2031

Figure 58: Latin America Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Application, 2021–2031

Figure 59: Latin America Cell Line Authentication and Characterization Tests Market Value Share Analysis, by End-user, 2020 and 2031

Figure 60: Latin America Cell Line Authentication and Characterization Tests Market attractiveness index Analysis, by End-user, 2021–2031

Figure 61: Middle East & Africa Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 62: Middle East & Africa Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 63: Middle East & Africa Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 64: Middle East & Africa Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 65: Middle East & Africa Cell Line Authentication and Characterization Tests Market Attractiveness Index Analysis, by Test Type, 2021–2031

Figure 66: Middle East & Africa Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Application, 2020 and 2031

Figure 67: Middle East & Africa Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Application, 2021–2031

Figure 68: Middle East & Africa Cell Line Authentication and Characterization Tests Market Value Share Analysis, by End-user, 2020 and 2031

Figure 69: Middle East & Africa Cell Line Authentication and Characterization Tests Market attractiveness index Analysis, by End-user, 2021–2031

List of Tables

List of Tables

Table 01: Global Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Test Type, 2017-2031

Table 02: Global Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 03: Global Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 07: North America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 08: North America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 11: Europe Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 12: Europe Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 15: Asia Pacific Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 16: Asia Pacific Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 19: Latin America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 20: Latin America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 23: Middle East & Africa Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 24: Middle East & Africa Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by End-user, 2017–2031